infection could be mimicking vasculitis. However, if a patient's disease is refractory to one remission induction therapy, it is important to change the remission induction strategy. We recommend switching to the other remission induction agent prior to using combination therapy. Recommendation: For patients with GPA/MPA that is refractory to remission induction therapy, we conditionally recommend adding IV immunoglobulin (IVIG) to current therapy. IVIG should not be used routinely to treat